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and untreatable, it may preclude them from seeking treatment. Third, MHLt posits 
that KABs collectively determine HSB unidirectionally. A bidirectional relationship 
may be more appropriate because patient behavior and human decision-making 
are fluid and constantly changing. In addition, this bidirectional relationship allows 
for a period of assessment necessary for patients to weigh their KABs against the 
current situation. Lastly, another needed component is resource availability (e.g., 
access to care and insurance status). In conclusion, as the first theory to conceptual-
ize literacy regarding mental health, the MHLt laid the foundation for exploring the 
relationship between KABs and HSB however, several improvements and additions 
to the theory may advance this body of work.
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The expiry dates mentioned on the medicines are considered inviolable by the 
patients. Given by the manufacturer and approved by the highest regulatory agen-
cies of a country, expiry date is considered as the ultimate safeguard to ensure the 
safety of the medicine being used by the patients. Exaggerated expiration dates 
pose economic burden on the health care system of a country, the effect being 
more significant in the underdeveloped and developing economies. In developed 
countries these issues have been addressed by using pharmacoeconomic tools like 
a. Cost- minimization analysis b. Cost- effective analysis c. Cost- utility analysis d. 
Cost- benefit analysis. The outcome of the studies conducted under the Shelf Life 
Extension Program by FDA clearly indicate that pre-occupation with the safety 
issues has resulted in all stake-holders being too conservative about the expiry 
dates. This results in the wasteful disposal of the drugs which are still therapeuti-
cally effective after their labelled expiry dates. This article discusses the general 
societal notions about the expiry dates of the drugs, the procedures being generally 
followed by pharmaceutical industries to give the expiration dates to the drugs, 
cases where the expiry dates have been extended by the regulatory agencies them-
selves and a testing program that started as an Air Force initiative in collaboration 
with FDA and saved American taxpayers millions of dollars. The article also recom-
mends the scientific course that may be taken towards a more pragmatic approach 
towards the expiry date labelling.
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Objectives: At present, the digital divide is generally considered a problem of 
access. This perspective is perpetuated by several assumptions regarding the 
availability, usability, and content of current health information and technological 
communications (ICT) promoting chronic care management. These biases serve to 
limit benefits of health technology innovation among the medically underserved 
or at-risk patient populations. Most prominent, the myths of ready access and sus-
tained engagement are presented - both of which differentially expose already 
vulnerable groups to fewer technological advances to improve patient care readily 
available to other groups in addition to poorer quality information to base medi-
cal decisions upon, thus reinforcing disengagement and potentially widening the 
divide. MethOds: By drawing on a range of literatures, including health com-
munications, medical informatics, social determinants of health, health behav-
ior and promotion, the purpose of this work is to deconstruct the divide, describe 
its importance and impact in health care settings, in an effort to improve under-
standing of its role in medication adherence and patient engagement in order to 
inform tailored intervention development. Results: Specifically, this conceptual 
work describes elements and challenges assumptions driving the divide in order 
to: expand understanding of the digital divide in practice, recognize important 
patient groups are being negatively impacted, and increase awareness of eHealth 
literacy and efficacy that may directly impact adherence and patient engagement. 
Examples of patient-centered technology tools are provided, such as the Personal 
Health Record (PHR), illustrating the potential for reducing as well as increasing the 
digital divide; if features of the divide are not considered when developing techno-
logically-based behavioral interventions, those relying on health ICT may serve to 
amplify inequalities in health and health care. cOnclusiOns: Conclusions elu-
cidating the elements upon which patient-centered interventions may be tailored 
appropriately are offered, providing suggestions to inform both population-based 
as well as individual-based health management strategies.
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intROductiOn: Judicialization of health is the terminology that refers to the sig-
nificant increase in lawsuits (legal queries) aiming to provide drugs and medical 
treatments. In this sense, since the role of the Judiciary is considered essential to 
confirm the social and constitutional rights to health, the legal sentences provoke 
a point of tension for policy-makers and for the government, compelled to ensure 
provisions that are in conflict with the budget established and policies for the 
health care sector. Objectives: To describe the importance of Health Technology 
Assessment (HTA) in helping to orientate judges, patients, policy-makers and other 
legal actors in lawsuits. MethOds: Analytical paper. Results: The evolution of 
medicine requires programmatic bias about the right to health, as always there will 
be new discoveries, new procedures, new diseases or the return of once eradicated 
diseases. Studies on efficacy, safety, effectiveness and cost-effectiveness are the 
main components of the Health Technology Assessment (HTA) field, which can be 
the importance of POLs, to propose a method to measure a POL’s influence, and to 
examine the possible roles of POLs.
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Objective: The life sciences and health technology (LSHT) sector is one of the key 
knowledge based area in Quebec. It provides for economic growth, wealth creation 
and quality of life improvement. The LSHT sector has been experiencing important 
changes of its R&D model over the past 5 years, hense modifying resources alloca-
tion. The objective of this analysis was to describe the LSHT in Quebec, look at its 
recent evolution and identify key elements of success contributing to grow this 
sector. MethOds: Information, gathered from the Quebec ministry of finance and 
economy, Quebec Institute of Statistics, Statistics Canada, Montréal International, 
US Bureau of Labor Statistics, Eurostat and Europe Innova, was used to develop a 
comparative analysis of the LSHT sector concerning wealth creation and economic 
growth for selected LSHT sub-sector in selected Canadian provinces, US states and 
European regions. The following information was gathered for the analysis: public 
and private employment and salaries (direct and indirect), gross domestic product 
(GDP), concentration of employment. Results: The analysis shows that the LSHT 
sector accounts for 1.5% of Quebec GDP and that employment in this sector gener-
ates more value (+70%) when compared to all the other economic sectors taken 
together. The comparative analysis, based on 35 regions in Europe, United States 
and Canada, shows that Quebec is one of the 3 regions with a diversified LSHT sec-
tor while other regions have specialized in one subsector (biotechnology, medical 
technology, pharma). The results show also that only 22% of regions grew between 
2008-2012. cOnclusiOn: This analysis suggests that the growth of LSHT cannot 
only be explained by the diversity of the subsector activities. The presence of large 
research and health centers as well as collaborative approach could explain the 
success for that growth. Further analysis would be required to measure the impact 
of each of these factors.
PHP137
transfEraBility of intErnational EvidEncE on tHE BEnEfits of 
innovativE mEdicinEs into cEntral EastErn EuroPEan countriEs
Inotai A.1, Kalo Z.2, Petrova G.3, Vitezic D.4
1Syreon Research Institute, Budapest, Hungary, 2Eötvös Loránd University, Budapest, Hungary, 
3Medical University of Sofia, Faculty of Pharmacy, Sofia, Bulgaria, 4University of Rijeka Medical 
School and University Hospital Centre Rijeka, Rijeka, Croatia
Objectives: Pharmaceutical stakeholders in Central Eastern Europe (CEE) often 
refer to international evidence from other jurisdictions to express the benefits of 
innovative medicines in cost savings or productivity gain. One of the most fre-
quently cited statements argues that increased expenditure on innovative medi-
cines may be offset by reduced hospital stay or avoided complications. Another 
popular argument is to express the value of modern medicines with the potential 
link between life expectancy and GDP growth. The aim of this research is to evalu-
ate the transferability of the most frequently referred international case studies 
to CEE. MethOds: Detailed literature review and appraisal of the transferability 
of these approaches to CEE. Results: CEE countries differ in several important 
aspects from high income countries: the overall health status of the population 
is worse; the price level of health care services is lower, mainly due to lower man-
power costs. On the contrary there is no significant difference in the price level of 
innovative medicines compared to high income countries. As the relative cost of 
hospitalisation is lower than cost of medicines in CEE countries, the cost saving 
potential from avoided hospitalisation and complications is more limited. As an 
average person in CEE countries lives longer than the retirement age, it is difficult 
to judge how additional life-years of inactive populations can increase productivity 
gain and consequently how it may contribute to GDP growth. As increased longev-
ity increases health expenditure, the major benefit of innovative medicines can 
be health gain in CEE. cOnclusiOns: The expectation to control overall health 
expenditure by extensive use of innovative drugs is unrealistic in the CEE region. 
Transferability of real world evidence on the benefits of innovative medicines from 
high income countries to lower income countries is limited.
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Mental illness (MI) is a national problem and over 60% of people who suffer from 
MI do not receive treatment. Understanding factors that may impact treatment 
seeking is important in developing effective intervention programs. Mental Health 
Literacy theory (MHLt) purports that one’s knowledge, attitudes and beliefs (KABs) 
about the following MI domains: 1)causes; 2)recognition; 3)how to seek information; 
and 4)sources of help can predict their help-seeking behaviors (HSB). The purpose 
of this paper is to critically evaluate the predictors and directionality of MHLt. This 
systematic analysis resulted in meaningful alterations to the theory based upon the 
need for the individual’s perspective on MI. MHLt conceptualizes the level of one’s 
literacy from a ‘top down’ approach. If a patient’s KABs are contrary to those of the 
professional community, then the patient is deemed to have low MHL. This approach 
minimizes patients’ experiences and beliefs, and may place the views of the pro-
fessional at odds with that of the patient resulting in disillusionment and distrust 
of the health care system. Second, MHLt neglects the role of prevention and self-
management, which is problematic because if a patient views MI as unpreventable 
